Approved

Nonapeptide-1: Uses, Research Status, and Safety Data

Molecular formulaC61H87N15O9S
Molecular weight1206.5 g/mol
Registered trials0
PubChem CID10418849

Regulatory status

Nonapeptide-1 does not carry an FDA-approved label. It is discussed here strictly as a research compound, and no approved indications, dosing, or clinical benefit claims apply.

What nonapeptide-1 is

Nonapeptide-1 is a synthetic peptide with the molecular formula C61H87N15O9S and a molecular weight of approximately 1206.5 g/mol (PubChem CID 10418849). Beyond its chemical identity, no FDA label or approved mechanism-of-action description exists for this compound.

Trial footprint

There are no registered clinical trials for nonapeptide-1 in the dataset reviewed, and no trial records were available to summarize phase or status information.

FAQ

Is nonapeptide-1 FDA approved?
No. Nonapeptide-1 has no FDA-approved label, indication, or brand name. Any use outside of formal research is not supported by regulatory approval.
What is nonapeptide-1 chemically?
It is a synthetic peptide with the molecular formula C61H87N15O9S and a molecular weight of about 1206.5 g/mol. It is catalogued in PubChem under CID 10418849.
Are there clinical trials studying nonapeptide-1?
Based on the data reviewed, there are no registered clinical trials for nonapeptide-1. This means there is no trial-based evidence available to describe its effects in humans.
What are the reported side effects of nonapeptide-1?
No adverse event reports were available for nonapeptide-1 in the dataset reviewed. This does not mean the compound is free of risk, only that no report data exists to summarize.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 10418849 ClinicalTrials.gov registry search

Updated 2026-09-19